Shopping Cart
- Remove All
Your shopping cart is currently empty
Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 200 mg | $29 | In Stock |
| Description | Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes. |
| Targets&IC50 | Pancreatic lipase (rat):54.8 nM, Pancreatic lipase (human):5.95 nM |
| Synonyms | ATL-962 |
| Molecular Weight | 401.58 |
| Formula | C25H39NO3 |
| Cas No. | 282526-98-1 |
| Smiles | O=C1C=2C(N=C(OCCCCCCCCCCCCCCCC)O1)=CC=C(C)C2 |
| Relative Density. | 1.02 g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: Insoluble DMSO: Insoluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.